Document is current
Any future updates will be listed below
-
Authors
Li, Rongkun https://orcid.org/0000-0002-0056-2025
Ji, Qian
Fu, Shengqiao
Gu, Jichun
Liu, Dejun https://orcid.org/0000-0002-8091-0375
Wang, Lu
Yuan, Xiao
Wen, Yi https://orcid.org/0009-0009-9572-1049
Dai, Chunhua https://orcid.org/0000-0002-6423-5445
Li, Hengchao https://orcid.org/0000-0002-4681-3854
- License Information
-
More Information
Article History
Received: 8 May 2024
Revised: 19 November 2024
Accepted: 4 December 2024
First Online: 17 December 2024
Competing interests
: The authors declare no competing interests.
: The use of human pancreatic cancer specimens was approved by the Research Ethics Committee of Renji Hospital (Ethics No. RA-2017-096). Informed consent was obtained from all subjects involved in the study. The human specimens were de-identified and all methods using the human specimens in this study were performed in accordance with the relevant guidelines and regulations. All animal experiments were approved by the Jiangsu University Animal Ethics and Experimentation Committee (License: SYXK (S) 2018-0053).
